Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 4
2005 2
2006 1
2007 1
2008 3
2009 2
2010 2
2011 3
2012 9
2013 8
2014 6
2015 8
2016 7
2017 4
2018 3
2019 6
2020 5
2021 6
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies.
Silverii GA, Gabutti G, Tafuri S, Sarti F, Pratesi A, Clerico A, Fornengo R, Greco C, Irace C, Sordi V, Sorice GP, Cavallo M, Ponziani MC, Mannucci E, Dicembrini I; SID-AMD-SItI Working Group on Diabetes, Vaccines. Silverii GA, et al. Among authors: irace c. Acta Diabetol. 2024 Apr 29. doi: 10.1007/s00592-024-02282-5. Online ahead of print. Acta Diabetol. 2024. PMID: 38684540
Elevated blood flow in people with type 1 and type 2 diabetes.
Cutruzzolà A, Parise M, Cozza P, Moraru S, Gnasso A, Irace C. Cutruzzolà A, et al. Among authors: irace c. Diabetes Res Clin Pract. 2024 Feb;208:111110. doi: 10.1016/j.diabres.2024.111110. Epub 2024 Jan 24. Diabetes Res Clin Pract. 2024. PMID: 38278495
Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial.
Russell-Jones D, Babazono T, Cailleteau R, Engberg S, Irace C, Kjaersgaard MIS, Mathieu C, Rosenstock J, Woo V, Klonoff DC. Russell-Jones D, et al. Among authors: irace c. Lancet. 2023 Nov 4;402(10413):1636-1647. doi: 10.1016/S0140-6736(23)02179-7. Epub 2023 Oct 17. Lancet. 2023. PMID: 37863084 Free article. Clinical Trial.
Continuous Glucose Monitoring-Derived Metrics and Capillary Vessel Density in Subjects with Type 1 Diabetes without Diabetic Retinopathy.
Cutruzzolà A, Carnevali A, Gatti V, Latella G, Lamonica L, Oliverio F, Borelli M, Parise M, Di Molfetta S, Scorcia V, Irace C, Gnasso A. Cutruzzolà A, et al. Among authors: irace c. J Diabetes Res. 2023 Apr 15;2023:9516059. doi: 10.1155/2023/9516059. eCollection 2023. J Diabetes Res. 2023. PMID: 37096234 Free PMC article.
A Head-to-Head Comparison of Two Algorithms for Adjusting Mealtime Insulin Doses Based on CGM Trend Arrows in Adult Patients with Type 1 Diabetes: Results from an Exploratory Study.
Parise M, Di Molfetta S, Graziano RT, Fiorentino R, Cutruzzolà A, Gnasso A, Irace C. Parise M, et al. Among authors: irace c. Int J Environ Res Public Health. 2023 Feb 23;20(5):3945. doi: 10.3390/ijerph20053945. Int J Environ Res Public Health. 2023. PMID: 36900956 Free PMC article. Clinical Trial.
90 results